Evaluation of Lipid-Lowering Therapy and Cholesterol Goal Attainment in Finland: The National FINRISK Study

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.6, Iss.5, 2006-01, pp. : 349-355

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

National guidelines for lipid-lowering therapy unsatisfactory

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 348, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Lipid-Lowering Therapy in Patients with Average Cholesterol and High Cardiovascular Risk, Insights from the Heart Protection Study

By Salam Amar

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 5, 2004-09 ,pp. : 387-389

Springer Publishing Company

Access to resources Recommend Favorite

Lipid Management and Cholesterol Goal Attainment in Norway

By Ose Leiv

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 2, 2006-01 ,pp. : 121-128

Adis International

Access to resources Recommend Favorite

Lipid-lowering therapy in diabetes

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 342, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Lipid-Modifying Therapy and Attainment of Cholesterol Goals in Hungary: The Return on Expenditure Achieved for Lipid Therapy (REALITY) Study

By Paragh György

Clinical Drug Investigation, Vol. 27, Iss. 9, 2007-01 ,pp. : 647-660

Adis International

Access to resources Recommend Favorite